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Abstract
Introduction: Patients with dystrophinopathies show low levels of neuronal nitric 
oxide	synthase	(nNOS),	due	to	reduced	or	absent	dystrophin	expression,	as	nNOS	is	
attached	 to	 the	 dystrophin-	associated	 protein	 complex.	 Deficient	 nNOS	 function	
leads to functional ischemia during muscle activity. Dystrophin- like proteins with 
nNOS	attached	have	also	been	identified	in	the	brain.	This	suggests	that	a	mecha-
nism of cerebral functional ischemia with attenuation of normal activation- related 
vascular response may cause changes in brain function.
Methods: The aim of this study was to investigate whether the brain response of 
patients	with	Becker	muscular	dystrophy	(BMD)	is	dysfunctional	compared	to	that	of	
healthy controls. To investigate a potential change in brain activation response in 
patients	with	BMD,	median	nerve	somatosensory	evoked	stimulation,	with	stimula-
tion	durations	of	2,	4,	and	10	s,	was	performed	while	recording	electroencephalogra-
phy	 and	 blood	 oxygen	 level-	dependent	 (BOLD)	 functional	 magnetic	 resonance	
imaging.
Results:	Results	in	14	male	patients	with	BMD	(36.2	±	9.9	years)	were	compared	with	
those	of	10	healthy	controls	(34.4	±	10.9	years).	Compared	to	controls,	the	patients	
with	 BMD	 showed	 sustained	 cortical	 electrical	 activity	 and	 a	 significant	 smaller	
BOLD	 activation	 in	 contralateral	 primary	 somatosensory	 cortex	 and	 bilaterally	 in	
secondary	somatosensory	cortex.	In	addition,	significant	activation	differences	were	
found	after	long	duration	(10	s)	stimuli	in	thalamus.
Conclusion:	An	altered	neurovascular	response	in	patients	with	BMD	may	increase	
our understanding of neurovascular coupling and the pathogenesis related to dystro-
phinopathy	and	nNOS.
K E Y W O R D S
Becker	muscular	dystrophy,	BOLD	signal,	case–control	study,	neurovascular	coupling,	
somatosensory evoked potentials
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1  | INTRODUC TION
Duchenne	 (DMD)	and	Becker	 (BMD)	muscular	dystrophies,	collec-
tively	called	dystrophinopathies,	are	X- linked and caused by muta-
tions	 in	the	dystrophin	gene.	DMD	and	BMD	are	characterized	by	
progressive	muscle	wasting,	cardiomyopathy,	and	a	reduced	life	ex-
pectancy	 (Bushby	et	al.,	1993,	2010a,b;	Emery,	2002).	However,	 a	
slower progression and less severe phenotype are seen in patients 
with	BMD	compared	 to	DMD.	Patients	with	BMD,	unlike	patients	
with	 DMD,	 typically	 carry	 in-	frame	 mutations	 of	 the	 dystrophin	
gene	preserving	some	residual	dystrophin	function	(Anthony	et	al.,	
2011).	In	addition	to	muscle	and	cardiac	involvement,	dystrophinop-
athies	 also	 involve	 cognitive	 symptoms.	 Patients	with	DMD	 score	
one	standard	deviation	below	normal	in	IQ	tests	(Cotton,	Voudouris,	
&	Greenwood,	2001),	and	behavioral	and	psychiatric	abnormalities	
have	also	been	reported	(Haenggi	&	Fritschy,	2006;	Waite,	Brown,	
&	Blake,	 2012;	Waite,	 Tinsley,	 Locke,	&	Blake,	 2009;	Young	et	al.,	
2007).	Patients	with	BMD	show	similar	deficits,	though	with	less	se-
verity	and	more	variability	(Chamova	et	al.,	2013;	Melo	et	al.,	1995).	
The pathophysiology of brain involvement in dystrophinopathies is 
not yet understood.
Reduced or absent dystrophin expression causes the membrane- 
bound	 dystrophin-	associated	 glycoprotein	 complex	 (DGC),	 pres-
ent	 in	 skeletal	 and	 cardiac	muscle	 cells	 (Hoffman	&	Kunkel,	 1989;	
Matsumura	&	Campbell,	1994)	as	well	as	the	neuromuscular	junction	
and	the	brain	(Nichols,	Takeda,	&	Yokota,	2015)	to	be	dysfunctional.	
This in turn may affect the regulation and distribution of brain blood 
flow	due	to	NO’s	vasodilatory	effect	exerted	on	the	smooth	muscle	
cells	of	the	brain	arterioles	(Attwell	et	al.,	2010).
In	patients	with	DMD,	compared	with	matched	controls,	struc-
tural	 abnormalities	 such	 as	 smaller	 total	 brain	 volume,	 reduced	
cerebral	 gray	matter	 volume,	 and	perfusion	deficits	were	 recently	
reported	(Doorenweerd	et	al.,	2014,	2017).	Functional	connectivity	
studies	showed	an	altered	neurovascular	activation	in	DMD	patients	
with	 blood	 oxygen	 level-	dependent	 (BOLD)	 changes	 in	 the	motor	
cortex measured by resting state functional magnetic resonance im-
aging	(fMRI)	(Lv	et	al.,	2011).	Such	studies	suggest	that	dystrophin	or	
proteins	in	the	DGC	play	an	important	functional	role	in	the	brain.	
Using	positron	emission	tomography	(PET),	reduced	brain	tissue	glu-
cose metabolism in sensorimotor areas was reported in patients with 
DMD	(Lee	et	al.,	2002).	Functional	brain	MRI	studies	in	patients	with	
DMD	are	few,	and	no	studies	have	been	undertaken	with	regard	to	
BMD.	Reports	from	a	different	muscular	disease,	myotonic	dystro-
phy,	 show	some	evidence	of	abnormalities	 in	 the	BOLD	response,	
both	 resting	 state	 and	 task-	induced	 responses	 (Okkersen	 et	al.,	
2017).
We	hypothesized	that	a	deficiency	in	dystrophin,	most	likely	as-
sociated	with	a	reduced	nNOS	expression	in	the	brain	similar	to	that	
shown	in	dystrophin-	deficient	muscle,	leads	to	an	altered	neurovas-
cular	response	in	patients	with	BMD.	As	a	result,	the	neurovascular	
coupling	would	be	altered	in	BMD	patients	compared	with	healthy	
subjects.	An	attenuation	of	NO	production	by	reduced	nNOS	levels	
would cause decreased cerebrovascular responsiveness to neuronal 
stimulation	causing	a	nonsufficient	supply	of	oxygen	and	glucose,	in	
particular during high demanding periods of repeated brain activa-
tion.	In	this	study,	we	apply	both	somatosensory	evoked	potentials	
(SEP)	and	fMRI	allowing	a	comparison	of	the	neurovascular	coupling	
with median nerve stimulation in the sensorimotor brain area.
2  | MATERIAL S AND METHODS
2.1 | Participants
Fourteen	males	affected	by	BMD,	carrying	previously	reported	mu-
tations	in	the	dystrophin	gene,	were	included	(Witting	et	al.,	2014).	
Ten healthy males with comparable handedness and age were stud-
ied	 for	 comparison	 (Table	1).	The	Ethics	Committee	of	 the	Capital	
Region	of	Denmark	approved	the	study,	and	all	subjects	gave	writ-
ten	informed	consent	according	to	the	Helsinki	Declaration	before	
participating. This study was part of a larger setup in which treat-
ment with sildenafil was investigated and compared in the patients 
(Lindberg	et	al.,	2017;	Witting	et	al.,	2014).	All	subjects	underwent	
two identical somatosensory electrical stimulation tasks: one out-
side	 the	 scanner	 with	 recorded	 EEG	 and	 one	 inside	 the	 scanner	
during	 BOLD-	fMRI	 recording.	 All	 parameters	 were	 kept	 constant	
between the two runs.
2.2 | Electrical stimulation
The delivery of the electrical impulses was carried out using a 
DS7A	 &	 DS7AH	 high-	voltage	 constant	 current	 electrical	 stimula-
tor	(Digitimer	Ltd,	United	Kingdom).	Median	nerve	stimulation	was	
performed	on	the	dominant	hand,	as	determined	by	the	Edinburgh	
Handedness	Scale	(Oldfield,	1971).	Each	stimulus	consisted	of	a	brief	
Becker patients 
N = 14
Healthy controls 
N = 10 p- value
Age 36.2	±	9.9	years 34.4	±	10.9	years .74a
Stimulation intensity 4.29	±	1.07	mA 4.81	±	1.07	mA .26b
Handedness	(right) 93% 90% .85b
SEP	N20-	P26	difference 0.89	±	0.49	μV 1.29	±	0.79	μV .14a
Mean	±	standard	deviation.
aTwo- sample two- sided t test.
bMann–Whitney	U test.
TABLE  1 Demography and group 
statistical comparisons
     |  3 of 9LINDBERG Et aL.
square pulse of 200 μs at an intensity of 80% of the motor threshold. 
The stimulation paradigm consisted of three different stimulation 
block	lengths	(2,	4,	and	10	s).	All	blocks	were	repeated	10	times	in	
a	random	order	with	a	stimulation	frequency	of	5	Hz	and	an	inter-
stimulus	block	interval	of	30	s	to	allow	the	BOLD	response	to	settle	
down	(Figure	1).	This	adds	to	a	total	of	30	stimulation	blocks	with	a	
total of 800 stimulations during the run.
2.3 | Magnetic resonance imaging
Magnetic	 resonance	 imaging	 was	 performed	 on	 a	 3.0T	 Philips	
Achieva	 scanner	 (Philips	Medical	 Systems,	Best,	 The	Netherlands)	
using	a	32-	channel	head	coil.	Anatomical	images	were	acquired	using	
a	MPRAGE	three-	dimensional	turbo	field-	echo	sequence	(137	sag-
ittal slices of 1.1 mm thickness; in- plane resolution 1 × 1 mm2; TR 
6,900	ms;	TE	2.8	ms;	TI	900	ms;	and	flip	angle	9°).
Acquisition	 of	 the	 functional	 images	 was	 performed	 using	 an	
echo planar imaging sequence (24 axial slices of 4.0 mm thickness; 
slice gap 0.1 mm; field of view 230 × 230 mm2; in- plane acquired 
resolution 1.8 × 1.8 mm2;	TR	2,000	ms;	TE	35	ms;	flip	angle	76°;	with	
SENSE	 (SENSitivity	Encoding)	 turned	off;	545	volumes).	The	slices	
were angulated and aligned to the extremities of the anterior and 
posterior	parts	of	corpus	callosum.	Magnetization	saturation	effects	
were	avoided	by	discarding	the	first	two	volumes	of	each	scan.	An	
online general linear model was performed on the Philips scanner 
software to monitor the performance and to assure that the electri-
cal stimulator was kept in place.
2.4 | Somatosensory evoked potentials
The	recording	of	the	somatosensory	evoked	potentials	(SEP)	out-
side the scanner was done using a 32- channel actiCap system 
(Brain	Products	GmbH,	Munich,	Germany)	placed	according	to	the	
international	 10–20	 standard	 electrode	 placement	 system.	 The	
participants	were	placed	on	the	same	table	as	used	inside	the	MRI	
scanner and the SEP data from channels C3 and C4 were acquired 
at	 5	kHz	 using	 the	 BrainVision	 Recorder	 software	 (Brain	 Amps	
GmbH,	Germany).
In	total,	800	electrical	median	nerve	stimulations	were	acquired.	
For	each	subject,	an	average	of	all	800	somatosensory	evoked	po-
tentials	(SEP)	from	1	to	200	ms	was	computed,	followed	by	averag-
ing the subjects within the two groups individually.
For	 all	 the	 stimulation	 blocks,	 each	 stimulation	 number	 in	 the	
train	of	stimulations,	sn,	was	averaged	individually	to	investigate	the	
time	effect	of	each	stimulus	in	the	train	(Figure	2).
Sn(t)=
1
Nk
Nk∑
k=1
Sn,k(t)
F IGURE  1  (Top)	Mean	time	courses	of	the	three	different	durations	(2,	4,	and	10	s)	from	one	subject.	(a)	BOLD	response.	(b)	Stimulation	
vector.	(c)	EEG	response	from	the	contralateral	channel.	(Bottom)	(d)	An	amplified	image	of	the	EEG	trace	for	the	4-	s	stimulation	period
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where Sn	is	the	mean	signal	of	all	the	stimulations,	n is the stimulation 
number	in	the	block,	and	k is the repetition number and Nk is
The	root	mean	square	 (RMS)	value	of	each	200	ms	stimulation	
period,	Sn,	was	then	calculated	and	normalized	to	the	value	of	 the	
first	 stimulation.	 Group	 comparison	 was	 then	 performed	 using	 a	
two- sample t	 test	 in	MATLAB	(The	MathWorks,	Natick,	MA,	USA)	
for each of the stimulations (n	=	2–20).
2.5 | Postprocessing
Postprocessing	and	statistical	analysis	of	 the	MRI	data	were	per-
formed	 using	 the	 FEAT	 (fMRI	 Expert	Analysis	 Tool)	 version	 6.00	
in	the	FSL	software	package	(Smith	et	al.,	2004)	(FMRIB	Software	
Library,	 Functional	 Magnetic	 Resonance	 Imaging	 of	 the	 Brain	
Center,	 Department	 of	 Clinical	 Neurology,	 University	 of	 Oxford,	
Oxford,	UK).	 The	data	were	brain	 extracted	with	 a	 fractional	 in-
tensity	 threshold	 of	 0.3,	motion	 corrected	 to	 the	 central	 volume	
using	6	degrees	of	freedom,	high-	pass	filtered	at	1/90	s,	and	spa-
tially	smoothed	using	a	full-	width	half-	maximum	Gaussian	kernel	of	
5	mm	before	general	linear	modeling	(GLM)	was	performed.	Three	
regressors	defining	the	stimulus	onsets	of	the	2-	,	4-	,	and	10-	s	stim-
ulation	blocks	(as	explained	in	the	section	on	electrical	stimulation)	
were convolved with a double- gamma hemodynamic response 
function	and	used	in	the	GLM.	Both	activations	and	deactivations	
were investigated. Significant clusters were determined from the 
Z- statistical images by a threshold of Z	>	2.3	and	a	(corrected)	clus-
ter significance threshold of p	=	.05	(Jezzard,	Matthews,	&	Smith,	
2003).	Familywise	error	correction	(FWE)	was	applied.	Functional	
images were registered to the structural T1 image using boundary- 
based	 registration,	 and	 the	 normalization	 to	 MNI-	152	 standard	
space was carried out between the structural T1 images and a 
1	mm	MNI-	152	standard	brain	by	a	linear	(12	degrees	of	freedom)	
and	 nonlinear	 registration	 (warp	 resolution	 of	 10	mm,	 10	mm,	
10	mm).	Groupwise	analysis	was	carried	out	using	FLAME	(FMRIB’s	
Local	Analysis	of	Mixed	Effects)	stage	1	with	a	column	describing	
the	patients	and	one	describing	the	controls.	Four	contrasts	were	
tested	 as	 follows:	 C1)	 average	 of	 the	 patient	 group,	 C2)	 average	
of	 the	 control	 group,	C3)	 patients	 greater	 than	 controls,	 and	C4)	
controls greater than patients. The group comparison results were 
overlaid	on	the	T1	1	mm	MNI-	152	standard	brain,	and	anatomical	
locations were defined using the Juelich histological atlas (Eickhoff 
et	al.,	2005).	To	investigate	effects	of	stimulus	duration	on	BOLD	
amplitude,	regression	analysis	testing	the	temporal	effects,	as	well	
as	group	differences,	was	carried	out	on	contralateral	SI,	SII,	and	
thalamus based on Juelich histological atlas segmentations. The 
postprocessing of the SEP data included band- pass filtering with 
cutoff	at	1–500	Hz,	segmentation	of	the	individual	stimuli,	and	av-
eraging	of	these,	all	done	in	MATLAB.
3  | RESULTS
Age	 and	 handedness	were	 not	 statistically	 different	 between	 the	
two	 groups	 (Table	1).	 The	 intensity	 of	 the	 applied	 stimulus	 to	 the	
dominant	median	nerve	was	(mean	±	SD)	4.29	±	1.07	mA	in	the	BMD	
group	and	4.81	±	1.07	mA	in	the	control	group,	which	was	not	sig-
nificantly	different	when	compared	using	a	Mann–Whitney	U test 
(p	=	.26).
The	voxelwise	group	statistics	are	reported	in	Figure	3,	with	the	
list	of	significant	clusters	summarized	in	Table	2.
3.1 | Blood oxygen level- dependent response
The two- second median nerve stimulation elicited a significant posi-
tive	BOLD	response	in	contralateral	primary	somatosensory	cortex	
(SI)	and	bilateral	activation	in	secondary	somatosensory	cortex	(SII)	
in	both	groups	 (Figure	3a,	patients	 and	Figure	3d,	 controls).	 In	 ad-
dition,	 the	 control	 group	 showed	 activation	 in	 the	 supplementary	
motor	area	(SMA)	to	the	median	nerve	stimulation.	The	group	com-
parison analysis showed a significantly stronger activation in the 
control	group,	mainly	localized	bilaterally	in	the	SII	and	contralateral	
SI	as	well	as	in	the	premotor	cortex	(Figure	3g).	The	BMD	group	had	
no areas of significantly stronger activations compared to the con-
trol	group	(Figure	3j).
The four- second stimulation induced the same activation pattern 
to median nerve stimulation as the two- second stimulation with the 
Nk=
⎧⎪⎨⎪⎩
30 for n≤10
20 for n>10
10 for n>20
≤20
F IGURE  2 Boxcar	stimulus	setup	(5	Hz).	Ten	of	each	block	was	presented	in	a	randomized	order.	The	narrow	lines	represent	each	
electrical stimulus within each stimulation block
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exception	that	activation	of	the	ipsilateral	SII	was	absent	in	the	BMD	
group	(Figure	3b,	patients	and	Figure	3e,	controls).	Group	compari-
son	did	not	reveal	differences	in	any	areas	(Figure	3h,k).
The group difference was further enhanced during the ten- 
second	stimulation,	where	the	BMD	group	only	showed	activation	
in	the	contralateral	SII	(Figure	3c,	patients	and	Figure	3f,	controls).	
The activation map of the control group was similar during the range 
of	stimulation	durations,	 though	with	a	decreased	contralateral	SI	
activation during the 10- s stimulation. Comparing the two groups 
revealed bilateral differences in thalamus activation with controls 
showing	 stronger	 activation	 (Figure	3i).	 The	 BMD	 group	 showed	
no areas of stronger activation compared to the control group 
(Figure	3l).
Analysis	 of	 voxelwise	deactivations	 showed	no	 consistent	pat-
tern for any of the stimulation durations and no significant differ-
ences in the group comparison.
Regression analysis of the atlas- based regions showed a sig-
nificant decrease with stimulus duration in contralateral SI in both 
groups (p	<	.001),	 but	 with	 no	 group	 difference	 when	 comparing	
slopes.	Neither	the	SII	nor	thalamus	showed	any	significant	decrease	
in	BOLD	amplitude	or	a	significant	group	difference	as	the	effect	of	
stimulus duration.
3.2 | Somatosensory Evoked Potentials
No	 significant	 difference	 (p	=	.14)	was	 found	 comparing	 the	N20-	
P26	SEP	amplitude	of	the	patient	and	control	groups.
The	RMS	value	of	each	stimulus	number	calculated	from	equa-
tion	1	showed	that	patients	with	BMD	had	a	significantly	 (p	<	.02)	
increased power when compared to healthy controls from stimulus 
9	and	onwards	(Figure	4).
4  | DISCUSSION
Investigating	the	neurovascular	response	in	patients	with	BMD,	we	
found	a	decreased	BOLD	response	contralateral	to	the	stimulation	
in	 the	primary	somatosensory	cortex	 (SI),	 as	well	as	bilaterally	 in	
the	secondary	somatosensory	cortex	(SII),	and	thalamus,	compared	
with	 healthy	 controls.	 In	 addition,	 a	 sustained	 EEG	 activity	 was	
detected during electrical somatosensory stimulation in patients 
with	 BMD	 in	 contrast	 to	 controls	 where	 the	 electrical	 activity	
dropped	and	levelled	off,	which	may	represent	neural	adaptation.	
Changes in the neurovascular response and functional stimulation- 
based	activations	using	MRI	have	not	previously	been	reported	in	
F IGURE  3 Mean	BOLD	activation	in	
the	BMD	group	(a–c).	The	2-	s	stimulation	
(a)	gives	a	strong	BOLD	response	in	
contralateral primary sensory cortex 
together with bilaterally in secondary 
somatosensory cortex. The response 
to	4-	s	stimulation	(b)	covers	the	
contralateral side both in primary- and 
secondary somatosensory cortex. The 
10-	s	stimulation	(c)	only	activates	the	
contralateral secondary somatosensory 
cortex.	Mean	BOLD	activation	in	the	
control	group	(d–f).	Both	2-	s	stimulation	
(d)	and	4-	s	stimulation	(e)	elicit	a	strong	
BOLD	response	in	contralateral	primary	
sensory cortex in addition to bilaterally 
secondary somatosensory cortex and 
thalamus.	10-	s	stimulation	(f)	shows	
activation only located to contralateral 
primary	somatosensory	cortex,	bilateral	
secondary	somatosensory	cortex,	and	
contralateral thalamus. Comparison 
between activation maps where controls 
have stronger activation than patients 
with	BMD	at	2-	(g),	4-	(h),	and	10-	s	(i)	
stimulation. Controls show a larger 
activation in the primary somatosensory 
cortex SI as well as the secondary 
somatosensory cortex SII to all stimulus 
durations. Thalamus differences are 
seen for the 10- s stimulation periods. 
No	significant	areas	were	found	testing	
for	patients	with	BMD	showing	stronger	
activation	than	controls	(j),	(k),	and	(l)
z−val
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patients	with	BMD	compared	 to	 healthy	 controls.	 Sensory	 func-
tion was chosen for investigation of neurovascular coupling in pa-
tients	with	BMD,	as	they	have	no	clinically	apparent	deficit	in	this	
area	and,	for	this	reason,	performance	issues	do	not	confound	the	
results.	The	decrease	in	BOLD	response	in	patients	could	be	due	to	
an	 insufficient	neurovascular	coupling,	 in	particular	 involving	 the	
NO	cascade	which	could	be	analogous	to	the	reduced	blood	flow	
response	during	muscle	activation	reported	in	patients	with	BMD.	
This interpretation is supported by reports of decreased expres-
sion	of	nNOS	in	neurons	that	lack	dystrophin	(Sogos,	Reali,	Fanni,	
Curto,	&	Gremo,	2003)	and	corresponds	well	with	the	decrease	in	
muscle	nNOS	found	in	our	patient	population	(Witting	et	al.,	2014).	
With dystrophin present in neurons and the microvasculature of 
the	brain,	a	cerebral	functional	ischemia	may	exist	similar	to	that	of	
skeletal	muscles	in	the	patients	with	BMD	(Rando,	2001),	though	
with	a	 less	 remarkable	clinical	 impact.	 Insufficient	NO	 in	 the	mi-
crovasculature of skeletal muscle is known to increase the suscep-
tibility	to	functional	ischemia,	which	leads	to	muscle	injury	during	
prolonged	 hypoxic	 muscle	 strain	 (Martin	 et	al.,	 2012;	 Thomas,	
2013).	In	the	present	study	of	patients	with	BMD,	treatment	with	
a	 phosphodiesterase	 5	 (PDE5)	 inhibitor	 resulted	 in	 a	 significant	
increase	 in	 the	 BOLD	 signal	 in	 somatosensory	 and	 visual	 areas,	
which	 indicates	 that	 the	 NO-	cGMP	 cascade	 could	 be	 involved	
(Lindberg	et	al.,	2017).
As	 previously	 reported	 in	 these	 patients,	 blood	 flow	 re-
sponse in the brachial artery was reduced during exercise 
(Witting	et	al.,	2014),	 though	without	 improved	response	after	
treatment	 with	 sildenafil,	 in	 contrast	 to	 the	 current	 findings.	
The	blood	flow	changes	represent	a	 large	artery	response,	but	
are still in line with reports on dysfunctional blood flow in the 
dystrophinopathies. Baseline cerebral perfusion is regulated 
by	both	large	artery	and	small	artery	responses,	and	influences	
the	size	of	the	BOLD	response	due	to	possible	vascular	ceiling	
effects	 (Birn	 &	 Bandettini,	 2005;	 Buxton,	 Uludağ,	 Dubowitz,	
&	 Liu,	 2004)	 which	 could	 affect	 brain	 activation	 BOLD	 data.	
A	lower	CBF	has	been	reported	in	young	DMD	boys	compared	
to	 healthy	 age-	matched	 controls	 (Doorenweerd	 et	al.,	 2017),	
which indicates that the patients could suffer from a dysfunc-
tional	 stimulus-	induced	CBF	 regulation	 leading	 to	 a	decreased	
BOLD	response.
The neuronal output to the vascular system during the median 
nerve	stimulation	was	increased	in	the	BMD	group	(Figure	4),	con-
trasting	to	a	decrease	observed	in	the	BOLD	response.	This	may	very	
well be in line with findings from a study on somatosensory evoked 
potentials	in	patients	with	myotonic	dystrophy,	although	a	different	
pathophysiology,	which	showed	abnormal	cortical	excitability	to	on-
going median nerve stimulation when compared to healthy controls 
(Mochizuki	 et	al.,	 2001).	 In	 general,	 amplitude	 coupling	 between	
F IGURE  4 Normalized	root	mean	square	(RMS)	value	of	neuronal	response	of	the	individual	stimulations	in	a	stimulus	train.	Patients	have	
a	more	sustained	activity	with	significant	higher	RMS	after	nine	stimulations	compared	to	healthy	controls.	Error	bars	are	standard	error	of	
the mean
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neural activity and vascular response is often considered nearly 
linear	 in	 the	healthy	brain	 (Li	&	Freeman,	2007;	 Logothetis,	Pauls,	
Augath,	Trinath,	&	Oeltermann,	2001),	but	a	change	in	the	coupling	
pattern	was	observed	in	the	present	study.	A	similar	uncoupling	of	
neuronal activity and metabolism has been reported in patients with 
mitochondrial	 encephalomyopathy,	 lactic	 acidosis,	 and	 stroke-	like	
episodes	(MELAS)	where	episodes	of	a	high	paroxystic	activity	occur	
concurrently	with	a	diminished	metabolism	and	cerebral	 flow	(Yeh	
et	al.,	2013).
A	decreased	activation	was	seen	bilaterally	in	thalamus	for	
the	4-	and	10-	s	stimulation	periods	in	the	patients	with	BMD	
vs.	 controls.	 The	 thalamus,	 in	 addition	 to	 passively	 relaying	
information	to	the	cortex,	appears	to	be	involved	in	response	
magnitude,	firing	mode,	and	synchrony	of	neurons	(Saalmann	
&	Kastner,	2011).	The	changes	 in	neuronal	activation	discov-
ered in this study could suggest changes in magnitude mod-
ulation	 in	 BMD	 patients,	 with	 altered	 sensory	 inputs	 in	 the	
thalamus leading to an altered adaptation measured in the 
cortex.	A	 thalamic	 involvement	 in	higher	order	 functions	has	
previously	 been	 described	 (Saalmann	 &	 Kastner,	 2011).	 Our	
results,	 however,	 suggest	 that	 the	 thalamic	 activation	 rep-
resents the stimulation of the somatosensory cortical areas 
and that this is merely a consequence of a general change in 
neurovascular	coupling,	 leading	to	a	 lower	BOLD	response	 in	
thalamus.
Stimulation strength was kept constant between the two 
groups,	and	variability	in	stimulation	intensity	could	therefore	not	
explain	the	intergroup	differences	in	the	results.	A	previous	study	
on	cortical	excitability	in	patients	with	DMD	did	not	show	any	dif-
ference	when	 compared	 to	 healthy	 controls	 (Yayla	 et	al.,	 2008).	
In	our	study,	 the	group	comparison	showed	more	prominent	dif-
ferences in the secondary somatosensory cortex in the control 
group	compared	to	the	patients	with	BMD	(Figure	3).	According	to	
Backes	et	al.	 (Backes,	Mess,	van	Kranen-	Mastenbroek,	&	Reulen,	
2000),	the	BOLD	response	remains	constant	regardless	of	the	ap-
plied stimulus intensity between 50 and 100% of motor threshold. 
Stimulus strength is therefore unlikely to have caused any group 
differences in the SII.
The current study showed a change in neurovascular response 
in	 BMD	 patients	 compared	 with	 controls,	 which	 could	 represent	
a	 change	 in	 the	neurovascular	 coupling.	A	 further	 investigation	of	
the functional impact of the insufficient neurovascular coupling 
in	patients	with	BMD	needs	to	be	established.	Further	studies	are	
needed to determine whether a deficient neurovascular coupling 
could impact the cognitive function.
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